PATENT CLAIM ANALYSIS

Application Number: 15771189
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "054000"]

Abstract:
A synthetic composition for use in improving one or more co-morbid mental disorder symptoms of a patient with IBS, characterised in that the composition contains an effective amount of one or more neutral human milk oligosaccharides, is disclosed.

Claim (Index 10):
A method for treating co-morbid mental disorders in a patient with irritable bowel syndrome (IBS) comprising orally administering to the patient an effective amount of a synthetic composition comprising one or more neutral human milk oligosaccharides (HMOs).

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.20588
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14407256', '15555936', '15579818', '14352596', '16071696']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7629205194566059
- 35 USC 102 Novelty (BERT): 0.5024592949945392
- Combined Prediction Score: 0.7368743970103993
- Mean Citation Score: 248.979548
- Max Citation Score: 268.4976
- Similarity Product: 202.67318088169097

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test